Brief: Biomed Lublin Says Hospital Files For Clinical Tests Regarding Immunoglobulina anty SARS-CoV-2

Synthaverse SA

16/11/2020 08:17

Nov 16 (Reuters) - Biomed Lublin Wytwornia Surowic I
Szczepionek SA  BML.WA :
    * SAID ON FRIDAY THAT A CLINICAL HOSPITAL IN LUBLIN HAS
FILED
MOTION TO POLAND'S MEDICINES AGENCY TO START CLINICAL TESTS
UNDER PROJECT REGARDING ANTI-SARS-COV-2 IMMUNOGLOBULIN
    * THE COMPANY SUPPLIES THE PREPARATION IT PRODUCES -
IMMUNOGLOBULINA ANTY SARS-COV-2    

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM6FMv5ca
    
 Further company coverage:  BML.WA  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))